Literature DB >> 10155261

Copayments for medicines. How much should patients pay?

M L Burstall.   

Abstract

Entities:  

Mesh:

Year:  1994        PMID: 10155261     DOI: 10.2165/00019053-199406030-00001

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN: 1170-7690            Impact factor:   4.981


× No keyword cloud information.
  6 in total

1.  The effect of patient charges on the utilisation of prescription medicines.

Authors:  B O'Brien
Journal:  J Health Econ       Date:  1989-03       Impact factor: 3.883

2.  The effects of cost sharing on the demand for prescription drugs in Belgium.

Authors:  E van Doorslaer
Journal:  Acta Hosp       Date:  1984

3.  The effect of drug co-payments on utilization and cost of pharmaceuticals in a health maintenance organization.

Authors:  B L Harris; A Stergachis; L D Ried
Journal:  Med Care       Date:  1990-10       Impact factor: 2.983

4.  Use of medical care in the Rand Health Insurance Experiment. Diagnosis- and service-specific analyses in a randomized controlled trial.

Authors:  K N Lohr; R H Brook; C J Kamberg; G A Goldberg; A Leibowitz; J Keesey; D Reboussin; J P Newhouse
Journal:  Med Care       Date:  1986-09       Impact factor: 2.983

5.  The demand for prescription drugs as a function of cost-sharing.

Authors:  A Leibowitz; W G Manning; J P Newhouse
Journal:  Soc Sci Med       Date:  1985       Impact factor: 4.634

6.  Health insurance and the demand for medical care: evidence from a randomized experiment.

Authors:  W G Manning; J P Newhouse; N Duan; E B Keeler; A Leibowitz; M S Marquis
Journal:  Am Econ Rev       Date:  1987-06
  6 in total
  2 in total

1.  The economic impact of Parkinson's disease. An estimation based on a 3-month prospective analysis.

Authors:  R C Dodel; M Singer; R Köhne-Volland; T Szucs; B Rathay; E Scholz; W H Oertel
Journal:  Pharmacoeconomics       Date:  1998-09       Impact factor: 4.981

Review 2.  Economic cost of male erectile dysfunction using a decision analytic model: for a hypothetical managed-care plan of 100,000 members.

Authors:  H L Tan
Journal:  Pharmacoeconomics       Date:  2000-01       Impact factor: 4.981

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.